Kisspeptin 45-54 (Kisspeptin-10) and Neuronal Cells: Hypothalamic Signaling, Reproduction, and Neuronal Models
Kisspeptin 45-54 — better known as kisspeptin-10 (KP-10) — is a 10–amino-acid fragment of the KISS1 precursor that activates the KISS1 receptor (GPR54) with nanomolar affinity. This research-use-only review examines its four best-studied roles in cells: driving hypothalamic GnRH/reproductive signaling, modulating ovarian granulosa steroidogenesis, shaping appetite-related transcripts, and — through a receptor-independent route — protecting cholinergic neurons from amyloid-β and α-synuclein toxicity.
Research-use-only disclaimer: Kisspeptin 45-54 is intended strictly for in-vitro and laboratory research use. It is not a drug, a supplement or an anti-aging product, and it is not intended for human or veterinary use to address cellular aging or cellular senescence, including administration via subcutaneous injection or intravenous infusion to alter systemic bioavailability. Every finding below is drawn from cell-culture or animal models and is described in hedged, mechanistic terms. Nothing here is medical advice for biohackers or patients, including for conditions like atherosclerosis.
TL;DR
Kisspeptin 45-54 (kisspeptin-10, sequence YNWNSFGLRF-NH2) activates the KISS1 receptor (GPR54) at ~1.6–2.3 nM affinity via Gq/Ca2+ signaling. In research models it probes hypothalamic GnRH release, raises granulosa-cell progesterone (via StAR / miR-1246), and shifts appetite transcripts. Notably, it also protects cholinergic neurons from amyloid-β and α-synuclein toxicity—often linked to Alzheimer’s, neurodegeneration, mitochondrial dysfunction, altered mitochondrial dynamics, the accumulation of reactive oxygen species (ROS), and oxidative stress—through a GPR54-independent mechanism, serving as a model for studying brain health and the role of a mitochondrial peptide in neuroprotection.
Identity: 10-aa KISS1 fragment (residues 45–54); retains full-length-like activity at GPR54.
Receptor: GPR54/KISS1R, Gq-coupled; Ki ~1.59 nM (rat) / 2.33 nM (human); Ca2+ mobilization without cAMP change.
Reproduction: raises Kiss-1/GnRH transcripts and c-Fos; concentration-dependent GnRH release; granulosa progesterone up via StAR and miR-1246 downregulation.
Neuroprotection: binds Aβ/PrP/IAPP and reduces toxicity; rescues cholinergic cells from α-synuclein — GPR54-independent, at ~0.1 µM.
Appetite: NPY up, BDNF down, dopamine/serotonin down in Hypo-E22 — an orexigenic-type profile in that model.
What Is Kisspeptin 45-54, and What Receptor Does It Hit?
Kisspeptin 45-54 is a synthetic 10-amino-acid peptide with the sequence Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2, corresponding to residues 45–54 of the KISS1 precursor. Despite being much shorter than the full-length precursor, it retains comparable intrinsic bioactivity at the KISS1 receptor — a point established in the founding work by Kotani et al. (2001), which identified kisspeptins as the natural ligands of the orphan receptor GPR54.
That receptor profile is why kisspeptin-10 is such a versatile probe, much like how MOTS-c, BPC-157, Epitalon, CoQ10, or elamipretide (developed by Stealth Biotherapeutics and also known as Bendavia or the SS-31 peptide) is used as a mitochondria-targeted peptide to study mitochondrial respiration and the inner mitochondrial membrane in models of Barth syndrome: a single, well-defined Gq/Ca 2+ input can be read out across very different cell types, from hypothalamic neurons to cardiomyocytes and ovarian granulosa cells.
How Does Kisspeptin 45-54 Act on Hypothalamic Neurons?
Research by Kanasaki et al. (2021) on immortalized hypothalamic neurons shows that kisspeptin 45-54 engages different transcriptional programs depending on the cell model. They compared two lines: mHypoA-50, derived from the anteroventral periventricular nucleus (AVPV), and mHypoA-55, derived from the arcuate nucleus (ARC). Both express endogenous Kiss-1 and GnRH transcripts and their receptors.
The responses diverged by nucleus. In mHypoA-50 (AVPV) cells, kisspeptin exposure raised Kiss-1 mRNA and kisspeptin protein while GnRH transcript stayed largely unchanged. In mHypoA-55 (ARC) cells, both Kiss-1 and GnRH mRNA rose together — suggesting nucleus-specific wiring shapes the downstream transcriptional response. In both lines, c-Fos protein rose after stimulation, a standard surrogate marker of neuronal activation. Because hypothalamic cells regulate many other neurons and endocrine cells, the authors framed kisspeptin and GnRH as "central regulators of the hypothalamic-pituitary-gonadal axis" at the cellular level.
How Does Kisspeptin 45-54 Drive the GnRH / Gonadotropic Axis?
Building on the transcriptional data, the peptide's downstream job is to modulate GnRH-producing neurons. Garcia et al. (2019) reported that kisspeptin 45-54 elicits GnRH release in a concentration-responsive fashion, with the magnitude shifting according to the maturation level of the model. Within this framework, kisspeptin-10 serves as a probe for how kisspeptin and neurokinin-B (NKB) neurons reciprocally modulate one another — the core "KNDy" circuitry that paces the reproductive axis.
Kisspeptin-10 in healthy volunteers
The cell and animal work on kisspeptin-10 has a small human counterpart: physiological studies in healthy volunteers that measured reproductive hormones over hours. George and colleagues reported the first study of kisspeptin-10 in men in 2011 (George et al. 2011). Healthy men received intravenous boluses of kisspeptin-10 or vehicle and, in a second part, infusions lasting up to 22.5 hours, while LH pulse frequency and size were estimated by deconvolution analysis (George et al. 2011). Serum LH rose rapidly after a bolus, the response increased with the amount given up to a maximum and was smaller at the highest amount tested, and a lower-rate infusion increased LH pulse frequency from 0.7 to 1.0 pulses per hour (George et al. 2011).
Jayasena and colleagues compared men and women in groups of four or five (Jayasena et al. 2011). LH and FSH rose in men after an intravenous bolus, but women in the follicular phase of the menstrual cycle showed no gonadotropin change with intravenous bolus, a bolus under the skin or intravenous infusion, even at the highest amounts tested; women in the preovulatory phase did respond (Jayasena et al. 2011). The authors described this as sexual dimorphism in the response to kisspeptin-10 (Jayasena et al. 2011). A 2015 single-blinded, placebo-controlled study from the same group gave healthy men kisspeptin-10, kisspeptin-54, GnRH or vehicle intravenously on separate days. At the amounts tested the two kisspeptins produced similar gonadotrophin secretion, and GnRH was more potent than either (Jayasena et al. 2015).
What Are Its Effects on Ovarian Granulosa Cells?
Kisspeptin-10's reach extends outside the brain. Guo et al. (2022) examined bovine granulosa cells (BGCs), focusing on progesterone (P4) biosynthesis and the microRNA miR-1246.
This peripheral action illustrates that kisspeptin signaling is not confined to central GnRH control — it can directly influence ovarian steroidogenic pathways in cultured cells.
How Does Kisspeptin 45-54 Interact with Amyloid-β and α-Synuclein?
A distinct line of work suggests kisspeptin-10 can bind misfolded, amyloidogenic peptides extracellularly and blunt their toxicity. Milton et al. (2012) reported that kisspeptin peptides bind amyloid-β (Aβ) and reduce its in-vitro toxicity, "[mitigating] the neurotoxicity of Aβ, PrP, and IAPP peptides, via an action that [may] not be blocked by kisspeptin-receptor (GPR-54) or neuropeptide FF (NPFF) receptor antagonists" — pointing to a direct peptide–peptide interaction rather than classical receptor signaling.
Given the structural overlap between the non-amyloid-β component (NAC) of α-synuclein (α-syn) and the C-terminus of Aβ, Simon et al. (2022) extended this to α-syn in cholinergic-differentiated SH-SY5Y cells.
A follow-up by Simon et al. (2023) in ChAT-positive SH-SY5Y neurons reinforced that KP-10 may reduce α-syn-associated apoptosis and mitochondrial depolarization independently of KISS1R—a mechanism sometimes explored in models of heart failure—and lowered α-syn and choline acetyltransferase (ChAT) immunoreactivity — hinting at engagement of intracellular aggregate-handling pathways. This has been framed in the context of dementia with Lewy bodies, where Aβ and α-syn co-accumulate in cholinergic neurons, though its receptor is also studied in unrelated contexts like stroke, heart disease, metabolic syndrome, heart failure and cardiac function, primary mitochondrial myopathy, age-related macular degeneration (AMD), chronic fatigue, fibrosis, diabetic nephropathy, or chronic kidney disease.
Does Kisspeptin-10 Affect Appetite Signaling?
Finally, Orlando et al. (2018) probed metabolic syndrome correlates and orexigenic markers in the Hypo-E22 hypothalamic cell line, tracking neuropeptide Y (NPY), BDNF, and monoamine turnover. Hypo-E22 cells tolerated the peptide; NPY gene expression rose while BDNF fell, and dopamine (DA) and serotonin (5-HT) content decreased (with increased DOPAC/DA and 5-HIAA/5-HT turnover ratios), while norepinephrine was largely unchanged. The authors read elevated NPY alongside reduced BDNF and 5-HT as a potentially orexigenic profile — though strictly within that in-vitro paradigm.
| Context | Model | Key reported finding |
|---|---|---|
| Receptor binding | KISS1R/GPR54 | Ki ~1.59 nM (rat) / 2.33 nM (human); Gq/Ca2+ |
| Hypothalamic | mHypoA-50 / mHypoA-55 | Kiss-1/GnRH mRNA & c-Fos shifts (nucleus-specific) |
| Reproductive | GnRH models | Concentration-dependent GnRH release |
| Ovarian | Bovine granulosa cells | ↑ P4, ↑ StAR, ↓ miR-1246 |
| Neuroprotection | Cholinergic SH-SY5Y | Rescues Aβ/α-syn toxicity (GPR54-independent) |
| Appetite | Hypo-E22 | ↑ NPY, ↓ BDNF, ↓ DA/5-HT |
How is research-grade kisspeptin 45-54 characterized?
Because the C-terminal amide (–Phe-NH2) is essential for KISS1R activity, identity and purity verification are especially important. Research-grade kisspeptin-10 is typically confirmed by reversed-phase HPLC for purity and mass spectrometry for identity (including amidation), handled cold, and supplied for laboratory use only as a water-soluble compound with high in-vitro bioavailability, often requiring reconstitution with bacteriostatic water in a lab setting. At PrymaLab, every lot is tested in its own laboratory by RP-HPLC for purity and LC-MS for identity, and the certificates can be checked at prymalab.net/testing/verify. No specific lot data are asserted in this general reference.
Half-life and breakdown of kisspeptin-10
Kisspeptin-10 and kisspeptin-54 share their last ten residues but behave differently in vivo. In male mice, d'Anglemont de Tassigny and colleagues found that kisspeptin-54 sustained LH release far longer than kisspeptin-10, and measured half-lives in the bloodstream of about 32 minutes and about 4 minutes respectively (d'Anglemont et al. 2017). Repeating kisspeptin-10 at short intervals over an hour did not reproduce the sustained LH rise seen after a single kisspeptin-54 bolus, so the authors concluded that clearance alone might not explain the difference and went on to test how well each peptide crosses the blood-brain barrier (d'Anglemont et al. 2017). For kisspeptin-54 in men, Dhillo and colleagues measured a plasma half-life of 27.6 minutes in an intravenous infusion study in six volunteers (Dhillo et al. 2005).
Breakdown has been characterised chemically too. Liu and colleagues built an LC-MS/MS assay for kisspeptin-10 in rat plasma with a lower limit of quantitation of 0.5 ng/mL, noting that earlier human pharmacokinetic work had relied on radioimmunoassay, which measures only immunoreactive kisspeptin (Liu et al. 2013). In their stability studies the peptide decomposed with half-lives of 6.8, 2.9 and 1.7 minutes at 4, 25 and 37 °C, and the principal decomposition product was kisspeptin-10 lacking its N-terminal tyrosine (Liu et al. 2013).
Frequently Asked Questions
What is kisspeptin 45-54?
It is a synthetic 10-amino-acid peptide (kisspeptin-10, YNWNSFGLRF-NH2) corresponding to residues 45–54 of the KISS1 precursor. It retains full-length-like activity at GPR54 and is for Research use only, similar to the laboratory application of MTP-131 to study cellular energy production, ischemia-reperfusion injury, exercise tolerance in animal models, mitochondrial bioenergetics, mitochondrial biogenesis, and the MPTP (mitochondrial permeability transition pore).
What receptor does kisspeptin-10 activate?
The KISS1 receptor (GPR54), a Gq-coupled GPCR, with Ki ~1.59 nM (rat)/2.33 nM (human). Activation mobilizes intracellular calcium without changing cAMP.
How does it affect reproduction?
It raises Kiss-1/GnRH transcripts and c-Fos in hypothalamic cells and triggers concentration-dependent GnRH release; in granulosa cells it raises progesterone via StAR and miR-1246 downregulation.
Can it protect neurons from amyloid or α-synuclein?
In research models, yes, via a GPR54-independent route. KP-10 (0.1 µM) suppressed wild-type and E46K α-synuclein apoptosis, preserved ATP production, and reduced mitochondrial depolarization even with the GPR54 antagonist KP-234 present (Simon et al.).
Does it affect appetite signaling?
In Hypo-E22 cells, Orlando et al. reported higher NPY, lower BDNF, and reduced dopamine/serotonin — an orexigenic-type profile in that model.
Is kisspeptin 45-54 approved for human use?
No. It is a research-use-only peptide studied in cell lines and animal models, not an approved drug, and not for human or veterinary use.
Related reading
- Oxytocin neuronal circuits: OXTR, reward and fear
- Gonadorelin (GnRH): pulses, half-life and the hCG switch
References
- Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631–34636. PMID:11457843
- Kanasaki H, Tumurbaatar T, Tumurgan Z, et al. Mutual Interactions Between GnRH and Kisspeptin in GnRH- and Kiss-1-Expressing Immortalized Hypothalamic Cell Models. Reprod Sci. 2021;28(12):3380–3389. PMID:34268716
- Garcia JP, Keen KL, Seminara SB, Terasawa E. Role of Kisspeptin and NKB in Puberty in Nonhuman Primates: Sex Differences. Semin Reprod Med. 2019;37(2):47–55. PMID:31847024
- Guo L, Xu H, Li Y, et al. Kisspeptin-10 Promotes Progesterone Synthesis in Bovine Ovarian Granulosa Cells via Downregulation of microRNA-1246. Genes (Basel). 2022;13(2):298. PMID:35205342
- Milton NGN, Chilumuri A, Rocha-Ferreira E, et al. Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro. ACS Chem Neurosci. 2012;3(9):706–719. PMC3447396
- Simon C, Soga T, Ahemad N, et al. Kisspeptin-10 Rescues Cholinergic Differentiated SHSY-5Y Cells from α-Synuclein-Induced Toxicity In Vitro. Int J Mol Sci. 2022;23(9):5193. PMC9105316
- Simon C, Soga T, Parhar I. Kisspeptin-10 Mitigates α-Synuclein-Mediated Mitochondrial Apoptosis in SH-SY5Y-Derived Neurons via a Kisspeptin Receptor-Independent Manner. Int J Mol Sci. 2023;24(7):6056. PMC10094180
- Orlando G, Leone S, Ferrante C, et al. Effects of Kisspeptin-10 on Hypothalamic Neuropeptides and Neurotransmitters Involved in Appetite Control. Molecules. 2018;23(12):3071. doi:10.3390/molecules23123071
Final disclaimer: This article is an educational research reference. Kisspeptin 45-54 is sold and studied for laboratory research use only, is not approved by any regulatory authority, and is not intended for human or veterinary use. Statements about kisspeptin 45-54 have not been evaluated by the FDA. Nothing here should be interpreted as medical advice.
Mechanistic descriptions are observations from cell lines and animal models of traumatic brain injury or diabetic nephropathy that may not generalize. Always verify the legal status of any research compound in your jurisdiction before purchase or use.
Formats stocked for the compounds in this article
KissPeptin-10: KissPeptin-10 (10mg), KissPeptin-10 5mg, Kisspeptin-10 10mg preloaded 3ml pen and Kisspeptin-10 10mg Nasal Spray. Every listing is supplied for laboratory research use with a batch certificate of analysis.
